Sonnet Biotherapeutics Holdings Inc 's Revenue per employee fell on a trailing twelve month basis to $ 111,111, below the company average number of $23,262.
Within the Healthcare sector Sonnet Biotherapeutics Holdings Inc achieved the highest revenue per employee. While revenue per employee remained unchanged compared to the previous quarter at no. .Sonnet Biotherapeutics Holdings Inc has 9 employees.

What is Sales per Employee Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Revenue per Employee▼

None ▼

Revenue per Employee▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

SONN Revenue per Employee	(Sep 30 2025) IV. Quarter	(Jun 30 2025) III. Quarter	(Mar 31 2025) II. Quarter	(Dec 31 2024) I. Quarter	(Sep 30 2024) IV. Quarter
Y / Y Revenue Change	-	-	-	5268.84 %	-
Sales per Employee (TTM) $	111,111	111,111	111,111	111,111	2,070
SONN's Total Ranking	#	#	#	#	#
Seq. Revenue Change	-	-	-	-	-

SONN Company Profile >> Back to SONN Efficiency Comparisons >> Compare SONN Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	#
Healthcare Sector	#
Overall Market	#

Revenue per Employee Statistics
High	Average	Low
$ 38,883	$ 23,262	$ 14,353
(Sep 30 2022)		(Dec 31 2023)

Financial Statements
Sonnet Biotherapeutics Holdings Inc 's Revenue MRQ	$ 0 Millions	Visit SONN's Income Statement
Sonnet Biotherapeutics Holdings Inc 's Revenues TTM	$ 1 Millions	Visit SONN's aggregate revenue growth
What are SONN's Sales?		Visit SONN's Sales by Segment

News about Sonnet Biotherapeutics Holdings Inc Revenue per employee

Sonnet Announces the Passing of Founder and CEO Pankaj Mohan, Ph.D.

A Legacy of Innovation: Sonnet BioTherapeutics Mourns Founder and CEO Pankaj Mohan, Ph.D. while Steering Forward Amid ChallengesPRINCETON, N.J. April 1, 2025 – In a profound moment of tragedy, Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) announced the unexpected passing of its esteemed founder and Chief Executive Officer, Pankaj Mohan, Ph.D. The news comes as a significant loss not just for the company but also for the broader biopharmaceutical industry where Dr. Mohan was recognized as a visionary leader dedicated to advancing cancer therapies through innovative research.Leadership TransitionIn the wake of this sorrowful event, the Board of Directors of Sonnet BioTherapeutics has acted decisively. They have appointed current board member Raghu Rao as the Interim Chief Executive Officer and promoted Stephen McAndrew, Ph.D. from Chief Business Officer to President and Chief Business Officer. This transition aims to ensure continuity during a challenging time as the Board initiates a search for a permanent CEO. While the company navigates through this difficult period, it remains focused on its mission to develop immunotherapeutic drugs targeted at the tumor microenvironment (TME).

Other Ratios
Sonnet Biotherapeutics Holdings Inc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
SONN's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for SONN's Competitors
Revenue per Employee for SONN's Suppliers
Revenue per Employee for SONN's Customers

You may also want to know
SONN's Sales Growth Rates	SONN's Pe Price to earnings ratio	SONN's Receivables Turnover Ratio	SONN's Stock Quote
SONN's Net Income Growth Rates	SONN's Ps Price to Sales ratio	SONN's Sales per Employee	SONN's Asset Turnover Ratio
SONN's Net Margin	SONN's Pb Price to Book ratio	SONN's Financial Strength Ratios	SONN's Dividend Payout Ratio

Date modified: 2026-08-29T07:16:11+00:00

Companies with similar Revenue per Employee for 12 months ending Sep 30 2025, within Healthcare Sector	Revenue per Employee	Revenue 12 months ending Sep 30 2025	Number of Employees Sep 30 2025
Marpai Inc	193,476.64	$ 20.702 Million	107
Fortrea Holdings Inc	193,000.00	$ 2,759.900 Million	14,300
Crispr Therapeutics Ag	190,731.34	$ 38.337 Million	201
Establishment Labs Holdings Inc	190,505.98	$ 191.268 Million	1,004
Quest Diagnostics Inc	190,350.88	$ 10,850.000 Million	57,000
Plus Therapeutics Inc	187,785.71	$ 5.258 Million	28
Viemed Healthcare Inc	184,366.14	$ 254.794 Million	1,382
Innovative Eyewear Inc	184,042.08	$ 2.393 Million	13
Retractable Technologies Inc	183,820.71	$ 36.948 Million	201
Kymera Therapeutics Inc	183,756.30	$ 43.734 Million	238
Seer Inc	181,188.89	$ 16.307 Million	90
Reshape Lifesciences Inc	180,312.61	$ 3.246 Million	18
Rapid Micro Biosystems Inc	178,497.08	$ 30.523 Million	171
Icu Medical Inc	178,428.92	$ 2,319.576 Million	13,000
Prothena Corporation Public Limited Company	175,910.45	$ 11.786 Million	67
Gyre Therapeutics Inc	173,567.96	$ 107.265 Million	618
Arcellx Inc	171,760.77	$ 35.898 Million	209
Ocular Therapeutix Inc	171,643.08	$ 55.784 Million	325
Iqvia Holdings Inc	171,010.75	$ 15,904.000 Million	93,000
Davita Inc	170,743.14	$ 13,317.965 Million	78,000
Septerna Inc	169,576.92	$ 22.045 Million	130
Universal Health Services Inc	167,413.82	$ 16,992.503 Million	101,500
Integer Holdings Corporation	165,167.55	$ 1,816.843 Million	11,000
Scynexis Inc	162,888.89	$ 2.932 Million	18
Concentra Group Holdings Parent Inc	160,721.38	$ 2,089.378 Million	13,000
Chemed Corporation	160,055.28	$ 2,530.634 Million	15,811
Grail Inc	155,853.85	$ 141.827 Million	910
Quipt Home Medical Corp	153,349.38	$ 245.359 Million	1,600
Intellia Therapeutics Inc	152,594.16	$ 57.528 Million	377
National Vision Holdings Inc	141,697.82	$ 1,861.626 Million	13,138

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.